Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM)   JULY 2014 , Volume 12 , Number 3; Page(s) 1 To 5.
 
Paper: 

VISFATIN AND RESISTIN SERUM LEVELS IN NORMAL-WEIGHT AND OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME

 
 
Author(s):  FARSHCHIAN FATEMEH, RAMEZANI TEHRANI FAHIMEH, AMIRRASOULI HOUSHANG*, RAHIMI POUR HOOMAN, HEDAYATI MEHDI, KAZEROUNI FARANAK, SOLTANI ADELEH
 
* MEDICAL LABORATORY TECHNOLOGY DEPARTMENT, SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES, TEHRAN, I.R. IRAN
 
Abstract: 

Background: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among women of reproductive age that is linked to insulin resistance and obesity. While studies have shown that plasma levels of resistin and visfatin increase with obesity, the association between PCOS and these markers has not been described well.
Objectives: This case-control study aimed to compare the serum levels of visfatin and resistin in women with PCOS in comparison with the healthy controls matched for age and body mass index (BMI).
Patients and Methods: A total of 80 women consisted of 40 women with PCOS and 40 matched eumenorrheic women without hyperandrogenism enrolled in the study. They were subcategorized into obese and normal-weight women according to their BMI. Serum visfatin and resistin levels were assessed using sandwich enzyme-linked Immunosorbent assay (ELISA).
Results: Serum levels of resistin were higher among both obese and normal-weight women with PCOS in comparison with the controls (2.36 and 1.58 ng/mL in normal-weight women with PCOS and controls, respectively; and 2.10 and 1.91 ng/mL in obese women with PCOS and controls, respectively). Serum visfatin levels was higher in both obese women with PCOS and controls (3.46 and 3.49 ng/mL PCOS and control groups, respectively) in comparison with normal-weight women in both groups (3.16 and 3.15 in PCOS and control groups, respectively); however; there were no statistically significant differences in serum resistin and visfatin levels between PCOS and control groups (P>0.05).
Conclusions: While the expression of visfatin and resistin may be upregulated in women with PCOS, it is not translated at serum level.

 
Keyword(s): POLYCYSTIC OVARY SYNDROME, VISFATIN, RESISTIN, OBESITY, BODY MASS INDEX
 
 
References: 
  • ندارد
  •  
 
Click to Cite.
APA: Copy

FARSHCHIAN, F., & RAMEZANI TEHRANI, F., & AMIRRASOULI, H., & RAHIMI POUR, H., & HEDAYATI, M., & KAZEROUNI, F., & SOLTANI, A. (2014). VISFATIN AND RESISTIN SERUM LEVELS IN NORMAL-WEIGHT AND OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), 12(3), 1-5. https://www.sid.ir/en/journal/ViewPaper.aspx?id=408074



Vancouver: Copy

FARSHCHIAN FATEMEH, RAMEZANI TEHRANI FAHIMEH, AMIRRASOULI HOUSHANG, RAHIMI POUR HOOMAN, HEDAYATI MEHDI, KAZEROUNI FARANAK, SOLTANI ADELEH. VISFATIN AND RESISTIN SERUM LEVELS IN NORMAL-WEIGHT AND OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM). 2014 [cited 2021May14];12(3):1-5. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=408074



IEEE: Copy

FARSHCHIAN, F., RAMEZANI TEHRANI, F., AMIRRASOULI, H., RAHIMI POUR, H., HEDAYATI, M., KAZEROUNI, F., SOLTANI, A., 2014. VISFATIN AND RESISTIN SERUM LEVELS IN NORMAL-WEIGHT AND OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), [online] 12(3), pp.1-5. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=408074.



 
  pdf-File
Yearly Visit 30
 
Latest on Blog
Enter SID Blog